Tag: global health security

IFPMA Policy Principles on COVID-19 Vaccines Initiative
Innovative vaccine industry strongly committed to rigorous regulatory standards for approval of COVID-19 vaccines
IFPMA Statement - Access to COVID-19 Tools Accelerator (ACT-Accelerator) Investment Case
IFPMA Statement at Gavi Alliance Global Vaccine Summit 2020 (Video)
Pharma pledges to continue 20 year partnership with Gavi, the Vaccine Alliance
Biopharmaceutical Industry Statement at Gavi, the Vaccine Alliance – Global Vaccine Summit 2020
IFPMA Statement on the “Solidarity Call to Action to realize equitable global access to COVID-19 health technologies through pooling of knowledge, intellectual property and data”
Global Biopharma CEO/Top Executives COVID-19 Media Briefing - 28 May 2020 (Video)
Pharma partners in efforts to give coronavirus vaccine for everyone
Pharma industry updates advice on engaging with healthcare professionals as countries emerge from COVID-19 lockdown
Ethical Considerations for Resuming In-Person Interactions with Healthcare Professionals Post COVID-19: A Guidance Document
Generation Gavi: Partnering to protect health through life-saving vaccines
Pharma and other innovative health groups tell World Health Assembly it stands united with governments and global health stakeholders worldwide to combat COVID-19
Joint Statement – Innovative Health Industries @ WHA73
COVID-19 Biopharmaceutical Industry – Regulatory Guiding Principles
IFPMA President David Ricks on Global Pledge Committing to Work Together to Beat COVID-19 (Video)
Pharma Joins Global Pledge Committing to Work Together to Beat COVID-19
Pharma Statement for The Coronavirus Global Response Pledging Marathon
Global Biopharma CEO/Top Executives Virtual Press Briefing - 30 April 2020 (Video)
Global Pharma update on unprecedented efforts to collaborate in speeding up the search for safe and effective COVID-19 therapies
Pharma industry body joins as founding partner a new global collaboration to accelerate the development, production and equitable access to new COVID-19 tools
IFPMA Statement on the launch of a new global collaboration to accelerate the development, production and equitable access to new COVID-19 tools
Innovative health industries united in welcoming United Nations General Assembly Resolution on “International Cooperation to ensure global access to medicines, vaccines and medical equipment to face COVID-19"
The value of the Ethos in the context of COVID-19
IFPMA remarks on intellectual property management and the global response to COVID-19
The biopharmaceutical industry commitments to tackle the coronavirus pandemic (Video playlist)
Pharma CEO/Top Executives Global Response to COVID-19 - Virtual Press Briefing - 19 March 2020 (Video)
Global Biopharmaceutical Industry Commitment to Address Coronavirus Public Health Crisis
Novel Coronavirus (COVID-19)
IFPMA and WHO Global Research and Innovation Forum

Other Tags

Access Access to antiretrovirals Access to Medicines Access to vaccines Africa AMR AMR Industry Alliance Anti-Counterfeit Antibiotics antimicrobial resistance antivirals Assembly Biosimilars Biotherapeutic Medicines Biotherapeutics Cancer Code of Practice collaboration Counterfeit Medicines Counterfeits COVID-19 Dementia Developing World Economic footprint Efficacy Epidemics Ethics Ethics; Code; Business integrity; Compliance Event Highlights Fake Medicines Fakes Falsified Medicines Fight the Fakes Flu Global Health global health security harmonization Health Partnerships HIV/AIDS IFPMA IFPMA Statement Immunization Incremental Innovation Influenza Influenza Vaccination Infographic Infographics Innovation Innovation ecosystem Intellectual Property IP IVS Malaria MDGs Medicines Mental and Neurological Disorders NCDs Neglected Tropical Diseases News Releases Non-Communicable Diseases Novel Coronavirus (COVID-19) NTDs pandemic Pandemic Influenza Pandemic preparedness pandemics Partnerships Pharma Pharmacovigilance Position Paper Prevention Publications Public Health Quality R&D Regulatory regulatory systems Related Links Research Safety SDGs Seasonal Influenza Statements Supply chain Sustainable Development Goals Sustainable Innovation trade Transparency Treatments Tuberculosis UHC Universal Health Coverage Vaccine Vaccines Value of Innovation Videos WHA WHO WIPO Women’s Cancers